Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.
about
The Need for Pediatric Formulations to Treat Children with HIVAdherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitatorsAdherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study.Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in EthiopiaSupporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights.Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules.Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medicationsAssessing medication adherence of perinatally HIV-infected children using caregiver interviews.Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countriesMeasuring adherence to antiretroviral therapy in children and adolescents in western Kenya.Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, TanzaniaAdherence to antibiotic prophylaxis in children with vesicoureteral reflux.Youths and HIV/AIDS: psychiatry's role in a changing epidemicAntiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa.Comprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected childrenPharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children.Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa.Compliance with antibiotic prophylaxis in children with vesicoureteral reflux: results from a national pharmacy claims database.Psychiatric symptoms and antiretroviral nonadherence in US youth with perinatal HIV: a longitudinal studyPrevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.Pharmacotherapy of pediatric HIV infectionThe perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting.Building adherence-competent communities: factors promoting children's adherence to anti-retroviral HIV/AIDS treatment in rural Zimbabwe.Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infectionAdherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.The role of etravirine in the management of treatment-experienced pediatric patients with HIV.Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.Children and Adolescents with Perinatal HIV-1 Infection: Factors Associated with Adherence to Treatment in the Brazilian Context.Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial.The role of cognitive functioning in medication adherence of children and adolescents with HIV infectionEffect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatmentThe adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities.Factors influencing adherence to anti-retroviral treatment in children with human immunodeficiency virus in South India--a qualitative study.A qualitative assessment of barriers to antiretroviral therapy adherence among adolescents in western Kenya.Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada.A meta-analysis of adherence to antiretroviral therapy and virologic responses in HIV-infected children, adolescents, and young adults.Cognitive interviewing for cross-cultural adaptation of pediatric antiretroviral therapy adherence measurement items.
P2860
Q26740369-91B1DE1F-4FCD-4AAF-8DE8-4AD98A5A9B21Q28469073-1C5D0616-0E69-40D6-8DC1-F68D04F71876Q30847604-E4E986E9-1606-484B-ACFD-5B9C6DDBE6C9Q33390518-5C4C3B99-D884-4B9F-AB18-2322559A39B8Q33481996-13167D56-3ACC-41CC-84FC-68B83320FBA7Q33514747-F968AFD9-61B4-4412-B77B-411D3387912CQ33885987-AEF11F1E-8C85-41DD-B7F8-A3A8366F3D49Q34087770-CC95DB82-196D-4006-AF9B-8B87293C931BQ34242255-2AC6874C-A7CA-41BA-B96E-768365DFC24FQ34513045-45C74EC3-7407-4E35-BBEC-521F7D455460Q34577449-10B04CFA-20D1-473B-BE21-28BB2BFC1697Q34773943-B02EF7E0-1FAE-41FB-BB7F-78491EDEFC86Q34983250-1E184AF5-0BE6-4CD7-8FEB-EC170B96E024Q35126792-17B6D5AA-7DDB-40C2-B8C7-FABC24AB90A7Q35350315-99CFE917-0E99-40A8-BB65-C98106F653CAQ35371115-44B8CFC9-F2FA-429A-A75E-383526A08AA3Q35488671-98FE8CD8-078B-4802-9DF0-273358DF909BQ35782466-946EC005-954C-4E0B-B6F7-56764E5E0371Q35810497-2DFA13BC-CEFB-4EB0-B6CF-284AC7CEEB9AQ35871280-099DA2F7-6413-4B43-8051-D357F6126263Q35920291-84583DB0-5C0A-46C9-989E-0D5A6DFFC253Q36186007-FE56B221-0AFB-472D-9630-EEF8E626C315Q36301325-A0A08679-6177-43AF-A6AF-FC8432D2BD2DQ36417430-F1126B90-CBAA-42F3-A266-D877FFBE8AEBQ36439546-B7369255-5DB0-49A1-A0E9-7B7B9829F4C9Q36513860-C204612A-6EDE-44FB-8FB7-C197A1ED7AD7Q36542643-943380D3-D080-4E90-9F1D-DC10ACAEEBDCQ36772619-746579B6-77FF-417D-83BC-8823BBA26E9AQ36833521-109C6478-E461-4A8E-9B68-F7960229347FQ37044889-3824781F-8667-436A-BE12-E9B9182E92EDQ37255631-7A065ED5-144F-41B6-BB95-89397DA42400Q37292619-9083BF19-9E2D-490E-ABBA-96D2823F6F64Q37509463-D49540CA-02D0-4BA5-BB7A-B7DE518F3D1BQ37628307-7E019048-7A55-4FBB-9FB6-B65CBFDF1995Q37660209-3AA46CD2-A5B6-4041-B8E5-8194B8598656Q37731768-7480D61B-8CBE-4AF4-9298-E40494B3DE7DQ37866289-72147E09-AB45-4CAA-8F5D-35ABF7625EAEQ37936388-0230B19D-1BDD-4619-812C-8EAEDFA927E8Q37992958-422FC6D9-4BE7-4C71-85AF-A62F4CE29894Q38063174-8460B278-6363-4DF7-A5D6-7E0EC650809F
P2860
Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Adherence to prescribed antire ...... children in the PENTA 5 trial.
@en
Adherence to prescribed antire ...... children in the PENTA 5 trial.
@nl
type
label
Adherence to prescribed antire ...... children in the PENTA 5 trial.
@en
Adherence to prescribed antire ...... children in the PENTA 5 trial.
@nl
prefLabel
Adherence to prescribed antire ...... children in the PENTA 5 trial.
@en
Adherence to prescribed antire ...... children in the PENTA 5 trial.
@nl
P2093
P1476
Adherence to prescribed antire ...... children in the PENTA 5 trial
@en
P2093
Alex Compagnucci
Hermione Lyall
Laura McGee
Paediatric European Network for Treatment of AIDS Steering Committee
Vania Giacomet
P356
10.1097/00006454-200301000-00015
P577
2003-01-01T00:00:00Z